The main limitation of the study is the underlying weakness of the studies evaluated. In the current study, researchers evaluated 10 randomized controlled trials that included comparisons either to another type of treatment or to a placebo, or dummy, treatment. The mean IELT of the patient was The patients’ satisfaction was significantly increased after treatment. Some studies suggest that between 20 and 30 percent of men report early ejaculation concerns, but the International Society for Sexual Medicine estimates that about 4 percent of men have a lifelong condition. Only a few patients experienced mild adverse events, including constipation, dry mouth, nose bleeding, abdominal pain, and lumbosacral pain, which were all relieved without drug withdrawal. Impact metrics.5 Min Read. (Reuters Health) – Complementary and alternative medicine options may help men manage premature ejaculation, according to a new review of . Yimusake Pian or Yimusake Tablets for impotence, premature ejaculation, spermatorrhea, nocturnal enuresis and neurasthenia. Regular price $ (72capsules*5 .  · Abstract Objective To objectively evaluate the efficacy and safety of Yimusake Tablet in the treatment of premature ejaculation (PE) through a multi .